Rucaparib (tartrate)
Rucaparib (AG014699) tartrate is an orally active, potent inhibitor of PARP proteins (PARP-1, PARP-2 and PARP-3) with a Ki of 1.4 nM for PARP1. Rucaparib tartrate is a modest hexose-6-phosphate dehydrogenase (H6PD) inhibitor. Rucaparib tartrate has the potential for castration-resistant prostate cancer (CRPC) research[1][2][3][4].
Product Specifications
CAS Number
[773059-22-6]
Product Name Alternative
AG-014699 (tartrate) ; PF-01367338 (tartrate)
UNSPSC
12352005
Target
PARP
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/rucaparib-tartrate.html
Solubility
10 mM in DMSO
Smiles
FC1=CC2=C3C(CCNC2=O)=C(C4=CC=C(CNC)C=C4)NC3=C1.OC([C@H](O)[C@@H](O)C(O)=O)=O
Molecular Formula
C23H24FN3O7
Molecular Weight
473.45
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
PARP1; PARP2; PARP3
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items